The distribution of serum C-reactive protein (CRP) levels and their association with age, sex, and atherosclerotic risk factors were studied in a large Japanese population between 1992 and 1995. The subjects consisted of 2,275 males and 3,832 females aged 30 years and over. CRP was measured by nephelometry. The distribution of CRP was highly skewed toward a lower level than that of previous studies and seemed to be a combination of two separate distribution curves. The increase in CRP with age was statistically significant, and males had higher CRP levels than did females. Males who were current smokers had higher CRP levels than did nonsmokers. Age, systolic blood pressure, diastolic blood pressure, triglycerides, fibrinogen, and body mass index were all positively associated with CRP in both sexes, while total cholesterol and blood glucose were positively related in females only. High density lipoprotein cholesterol was inversely related in both sexes. Multiple logistic regression analysis showed that sex, age, systolic pressure, high density lipoprotein cholesterol, triglycerides, fibrinogen, and body mass index were significant independent variables. In conclusion, the distribution of CRP among the Japanese was quite different from that among Westerners, although CRP levels correlated with other atherosclerotic risk factors, similar to those in Westerners. Am J Epidemiol
Although atherosclerosis is multifactorial, it is now widely recognized that systemic and localized inflammation in the arteries contributes to the initiation or promotion of cardiovascular disease (1) . C-reactive protein (CRP) is a protein of the acute-phase reaction of inflammation. It has been shown that elevated levels of serum CRP are related to a poorer outcome in patients with cardiovascular diseases (2, 3) . Recently, several studies have suggested that CRP is a predictor of subsequent cardiovascular events in healthy adults (4) (5) (6) (7) .
However, to our knowledge, there have been only two reports on the distribution of serum CRP levels in a largescale, population-based study that included both males and females and used a hypersensitive assay (8, 9) . Moreover, the relation between CRP and atherosclerotic risk factors in females has been reported in only a few studies (6) (7) (8) 10) . The Jichi Medical School Cohort Study is a prospective, population-based study that aims to explore the risk factors for cardiovascular and cerebrovascular diseases in Japan. The subjects included people of both sexes aged 30 years and over residing in areas throughout Japan.
In this report, we show the distribution of serum CRP levels and the relation between serum CRP levels and atherosclerotic risk factors in a large group of healthy people aged 30 years and over.
MATERIALS AND METHODS
The study design and some descriptive data have been presented previously (11) (12) (13) . The population for our study included residents of nine rural communities in Japan, including Yamato, Takasu, Wara, Sakuma, Hokutan, Sakugi, Ohkawa, Ainoshima, and Akaike. In Japan, mass screening for cardiocerebrovascular diseases has been conducted since 1982, according to the Health and Medical Service Law for the Aged Act of 1981. Invitations to this mass screening were issued by government offices in each community, and personal invitations were also sent to all the subjects by mail. However, the invitations mentioned that those who were receiving treatment at hospitals or clinics for cardiovascular or cerebrovascular diseases did not need to take the examination. As a result, 2,573 males and 4,186 females aged 30 years and over participated in these examinations. In this study, we excluded those who had had stroke or myocardial infarction as determined by a questionnaire or interview and those from whom some data were incomplete. The final number of study subjects was therefore 2,275 males and 3,832 females. The overall response rate was 52.4 percent; the rates in each community were 51.0 percent in Yamato, 63.0 percent in Takasu, 90.0 percent in Wara, 88.0 percent in Sakuma, 27.0 percent in Hokutan, 38.0 percent in Sakugi, 66.0 percent in Ohkawa, 44.0 percent in Ainoshima, and 26.0 percent in Akaike.
To obtain uniform information, we established a central committee composed of the chief medical officers from all participating areas, which developed a detailed manual for data collection. Medical history, habitual food intake, smoking habits, menopausal status, and alcohol consumption were assessed by a questionnaire developed by the committee. Females were considered postmenopausal if their menses had ceased naturally at least 12 months previously.
Body height was measured in stocking feet. Body weight was recorded with the subject clothed, and 0.5 kg in summer or 1 kg in other seasons was subtracted from the recorded weight. The body mass index was calculated as weight (kg)/height (m) 2 . Waist and hip circumferences were collected as optional measurements in Takasu, Wara, Sakuma, Ohkawa, and Ainoshima. There were 921 male and 1,276 female subjects. Waist circumference was measured at the level of the high point of the iliac crest, and hip circumference was measured at the level of maximum extension of the buttocks. The waist-to-hip ratio, calculated as waist circumference divided by hip circumference, was used as an indicator of abdominal visceral fat (14) .
The systolic and diastolic blood pressures were measured with a fully automated sphygmomanometer (BP203RV-II, Nippon Colin, Komaki, Japan), placed on the right arm of a seated subject who had rested in a sitting position for at least 5 minutes before the measurement.
Blood samples were drawn from the antecubital vein of seated subjects with minimal tourniquet use. Specimens were collected in siliconized vacuum glass tubes containing a 1/10 volume of 3.8 percent trisodium citrate for fibrinogen, sodium fluoride for blood glucose, and no additives for lipids, respectively. Tubes were centrifuged at 3,000 g for 15 minutes at room temperature. After separation, the serum samples were stored at 4˚C in refrigerated containers if analysis was to be performed within a few days. Otherwise, the samples were frozen until analysis. Plasma samples were frozen as rapidly as possible to -80˚C for storage until laboratory examination could be performed.
CRP levels were measured by using nephelometry, a latex particle-enhanced immunoassay (NA Latex CRP Kit, Dade Behring, Tokyo, Japan). The value in the calibrator was assigned from the Certified Reference Material 470 (IRMM, Geel, Belgium), an international plasma protein reference material. The material has achieved international standardization in the assay of CRP. The function of the assay was found to be satisfactory (15) . Its interassay and intraassay coefficients of variation (CV) were 1.18 and 1.36 percent, respectively. The assay is sensitive enough to detect 0.03 mg/liter of CRP. Undetectable CRP values were recorded as 0.015 mg/liter. Total cholesterol and triglycerides levels were measured by using an enzymatic method (Wako, Osaka, Japan; interassay CV: 1.5 percent for total cholesterol and 1.7 percent for triglycerides). High density lipoprotein cholesterol was measured by using the phosphotungstate precipitation method (Wako, Osaka, Japan; interassay CV: 1.8 percent). Blood glucose was measured by using an enzymatic method (Kanto Chemistry, Tokyo, Japan; interassay CV: 1.9 percent). Lipoprotein(a) levels were measured with an enzyme-linked immunosorbent assay kit (Biopool, Uppsala, Sweden; interassay CV: 3.51 percent). Fibrinogen levels were determined with a one-stage clotting assay kit (Data-Fi, Dade Behring, Miami, Florida; interassay CV: 2.5 percent). Serum insulin levels, which were collected in an optional examination that included 1,222 males and 1,663 females in Takasu, Wara, and Sakuma, were determined with a radioimmunoassay kit (Dainabot, Tokyo, Japan; interassay CV: 4.5 percent). The lower detection limit was 2.5 µU/ml, and insulin levels below this limit were taken as 2.0 µU/ml.
Statistical methods
Statistical analysis was performed using a Statistical Analysis System 6.12 edition (SAS Institute, Inc., Cary, North Carolina). Descriptive parameters were shown as the mean, standard deviation, and percentiles. For a comparison of the mean values, the unpaired t test, Mann-Whitney U test, or analysis of covariance with an adjustment for age was used. Categorical variables were analyzed by using the chi-square test. Serum CRP levels were divided into two categories, above and below 0.11 mg/liter, because the distribution appeared to be a combination of two separate distributions, with 0.11 mg/liter being the value at which these two distribution curves crossed. To assess the influence of each variable, logistic unconditioned regression models were used. Odds ratios were used to evaluate the association between CRP and other variables. As an additional observation, a multiple linear regression analysis was used in which the dependent variable was natural log-transformed CRP. In these multivariate analyses, we used two models, one that included and one that excluded the waist-to-hip ratio and insulin. Because these variables were measured as optional measurements in this study, they were taken for about one third of all the subjects in our study. The effect of menopausal status on CRP levels was analyzed in females aged 40-59 years, and those who had surgical menopause were excluded. The difference in CRP between premenopausal and postmenopausal women adjusted for age was studied with analysis of covariance. When parametric procedures were used, triglycerides, blood glucose, lipoprotein(a), and insulin were transformed into natural logarithms. A significant difference was defined as p < 0.05. Figure 1 shows the distribution of CRP levels among the study subjects. The distribution of serum CRP levels was highly skewed to lower levels and ranged widely. The minimum value was less than 0.03 mg/liter, and the maximum value was 68.2 mg/liter, with 25th, 50th, and 75th percentile values of less than 0.03, 0.12, and 0.30 mg/liter, respectively. The shape of the distribution did not differ by sex, age, or community. In this study, serum CRP levels seemed to have two distributions. One was a lower distribution with a narrow range, and the other was a higher distribution with a very wide range. We considered this to be a combination of two separate distributions and divided CRP levels into two categories: those lower than or equal to 0.11 mg/liter and those higher than 0.11 mg/liter. This was the value at which the two distribution curves were seen to cross. The mean value and standard deviation of the first subpopulation, which had lower CRP levels, were 0.038 and 0.024 mg/liter, respectively. Those of the second population, which had higher CRP levels, were 1.30 and 4.25 mg/liter, respectively. Table 1 shows the mean CRP levels by age and sex. The mean CRP levels increased with age in both sexes, except (table 2) . Age, systolic pressure, diastolic pressure, triglycerides, fibrinogen, body mass index, insulin, and waist-to-hip ratio were positively associated with CRP in both sexes. High density lipoprotein cholesterol was inversely associated with CRP levels in both sexes. Total cholesterol and blood glucose were correlated among females only, and smoking status was correlated among males only. No significant difference was detected with respect to lipoprotein(a). These associations were also seen after adjustment for age (data not shown).
RESULTS
Logistic regression analysis was performed on variables that were significantly correlated with CRP (table 3) . Male sex, age, systolic pressure, triglycerides, fibrinogen, body mass index, and current smoker status were positively correlated with CRP, while high density lipoprotein cholesterol was negatively correlated. When waist-to-hip ratio and insulin were included in the analysis (in a subset of 2,134 subjects), age, systolic pressure, fibrinogen, body mass index, current smoker status, and waist-to-hip ratio were positively associated with CRP. However, the associations with sex, high density lipoprotein cholesterol, and triglycerides disappeared. There was no significant association between insulin and CRP. As an additional observation, a multiple linear regression analysis, of which the dependent variable was natural log-transformed CRP, was conducted. There were 1,630 samples with CRP levels less than the lowest detection value (0.03 mg/liter); such samples were considered to be half of the lowest detection value (0.015 mg/liter) in this study. As shown in table 4, the associations of CRP and sex, age, systolic pressure, triglycerides, fibrinogen, body mass index, smoking status, and high density lipoprotein cholesterol were not basically different from the results from the logistic regression analysis, but a negative association between CRP and total cholesterol appeared. When waist-to-hip ratio and insulin were included in the analysis, age, systolic pressure, fibrinogen, body mass index, smoking status, and waist-to- hip ratio were positively associated with CRP, while total cholesterol and blood glucose were negatively associated. The associations with sex, high density lipoprotein cholesterol, and triglycerides disappeared. There was no significant association between insulin and CRP. CRP levels were compared with menopausal status. Premenopausal women tended to have lower CRP levels than did postmenopausal women. The age-adjusted geometric means were 0.08 and 0.10 mg/liter, respectively (p ϭ 0.10).
DISCUSSION
To the best of our knowledge, this is the first study to provide cross-sectional data in relation to atherosclerotic risk factors and serum CRP levels in a large-scale, populationbased study of the Japanese. An additional strength of this study was the quality of the sample collection and the precision of the CRP measurements, in which CV levels were lower than those reported in previous reports (5-7).
In previous studies, the distribution of serum CRP levels was skewed, with a log-normal distribution for males (16) (17) (18) . Koenig et al. (17) reported that the distribution of CRP levels was 55-80 percent for CRP values of less than 2 mg/liter, which is well below the range seen in routine CRP measurements used to monitor active inflammatory, infective, or tissue-damaging disorders (2, 4, 5, 7) . In addition, in other population-based studies that included both sexes, the distribution also showed log-normal distribution (8) (9) (10) . In our study, however, the distribution of CRP was highly † OR, odds ratio; CI, confidence interval; HDL, high density lipoprotein; BMI, body mass index. ‡ Odds ratio 1 included all of the subjects in the study. Odds ratio 2 included some subjects in the study with data on waist-to-hip ratio and insulin. Odds ratio for 1 standard deviation increase, except for sex and smoking status. * A numerical datum of lognormal C-reactive protein (lnCRP) as the dependent variable. A CRP level of less than the lowest detection value (0.03 mg/liter) was taken to be the half value (0.015 mg/liter).
† Coefficient 1 included all of the subjects in the study. ‡ CI, confidence interval; HDL, high density lipoprotein; BMI, body mass index. § Coefficient 2 included some subjects in the study with data on waist-to-hip ratio and insulin. skewed to lower levels than in previous studies (table 5) , with a median value of 0.12 mg/liter, and 94 percent with less than 2 mg/liter, and appeared to have a combination of different distributions.
In previous studies (8, 10, 16, 18) , the relations among serum CRP and atherosclerotic risk factors were inconsistent. Mendall et al. (16) and other investigators in the United States (10, 18) showed that CRP was related to several atherosclerotic risk factors, while Danesh et al. (8) found no association except for smoking status and body mass index. Our data showed results similar to those in the study by Mendall et al. and in other US studies, except for total cholesterol and blood glucose in males. Although the reasons for the discrepancies between our results and the report by Danesh et al. are unclear, some factors that may be involved are differences in CRP assays and ethnic differences on the clustering of risk factors. However, our results suggest that CRP may be a risk marker for atherosclerotic diseases in the Japanese, as well as in Westerners. In females, there was no difference between smokers and nonsmokers. Because there were few female smokers in this study, however, the effect of smoking among females could not be ascertained. Our results showed positive associations among CRP, body mass index, and waist-to-hip ratio, but not with insulin. Hak et al. (19) showed that CRP was associated with body mass index and waist and hip circumference, but not with waist-to-hip ratio after adjustment for body mass index in 186 healthy, middle-aged women. In our study, the association between CRP and waist circumference showed results similar to those with the waist-to-hip ratio (data not shown). All previous studies have shown a positive association between CRP and body mass index, and recently, an association among CRP, insulin, and obesity has been suggested (9, (19) (20) (21) (22) . The mechanisms for the reason CRP had a positive association with body mass index or obesity may be explained as follows. The main modulators of CRP are interleukin 1 and 6 and tumor necrosis factor alpha (23) . Adipocytes from obese humans have been shown to overproduce tumor necrosis factor alpha messenger RNA (24) . Tumor necrosis factor alpha is a potent inducer of interleukin 6 production in various cells, which may explain the positive association between CRP and body mass index (16) . In vitro, human abdominal visceral adipose tissue releases more interleukin 6 compared with subcutaneous adipose tissue (25) ; our data may support this. Although our data are cross-sectional and cannot address causality or exclude confounders that can explain the results, they suggest that CRP is strongly associated with fat distribution.
The sex difference in CRP is controversial. In our study, males had higher CRP levels than did females. This result was consistent with one nested case-control study of 89 males and 57 females aged 65 years and over (7) . One crosssectional study of 400 subjects, which included both sexes aged 65 years and over, showed that males and females had similar values (10) , while other studies showed that females had higher CRP levels than did males (6, 9) . The reasons for these discrepancies are unclear, but it is important to note that the females in this analysis had lower body mass index and lower rates of smoking, which are associated with decreased CRP, than those in previous studies. Although the sex difference in our analysis may reflect the fact that males were more likely than females to be current smokers, the difference remained even after adjustment for smoking status: This may reflect sex-specific effects. In our study, premenopausal women tended to have lower CRP levels than did postmenopausal women. Hak et al. (19) also showed that CRP levels were slightly higher in postmenopausal compared with premenopausal women, although this was not statistically significant. Although experimental data suggest an inhibitory effect of estrogens on interleukin 6 gene † Age not given in the paper. ‡ Numbers of subjects not given in the paper. The blank column not described in the paper. expression (19, 26) , recent studies suggested an increase in CRP with hormone replacement therapy (27) (28) (29) (30) (31) . However, in rural areas of Japan, hormone replacement therapy is not yet widely used, so we believe that the effect of this therapy was small in our analysis. We think, therefore, that sex hormonal effect may be one reason why females had lower CRP levels than did males.
In multivariate analyses, which included the waist-to-hip ratio and insulin, the results were different from those excluding these parameters. Although this may indicate that the waist-to-hip ratio has a stronger association with CRP than other variables, it is important to note that the data on waist-to-hip ratio and insulin included only about one third of all the subjects in our study. Therefore, we believe that the results including these data need to be considered carefully and that further studies are needed.
The much lower levels of CRP compared with previous studies may be due to the fact that our study population included females, who had very low smoking rates, and a lower body mass index. However, even taking these factors into consideration, the difference was considerable. This finding suggests, therefore, that the Japanese have lower CRP levels than do Westerners, which may be reflected in the lower coronary event rate among the Japanese.
In this study, CRP levels seemed to show a combination of two separate distributions. This finding cannot be explained, but it may indicate that the higher CRP group underwent subclinical atherosclerotic changes, possibly resulting in future atherosclerotic events.
In conclusion, serum CRP levels correlated with atherosclerotic risk factors in the Japanese as well as in Westerners. However, the distribution of CRP in this study was quite different from that in previous studies, suggesting that the Japanese have much lower CRP levels than do those of other developed countries and that this could reflect the low coronary event rate among the Japanese.
